Phui-Ly Liew – Datasets — Taipei Medical University

View Scopus Profile

Email11034s.tmu.edutw

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

2 results
- Title
- Start date(ascending)

Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. (Contributor), Wen, K. (Creator), Sung, P. (Contributor), Chou, Y. (Creator), Liew, P. (Contributor), Chen, L. (Contributor), Huang, R. (Creator), Lai, H. (Contributor) & Chang, L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
Dataset
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y. (Contributor), Wen, K. (Creator), Sung, P. (Contributor), Chou, Y. (Creator), Liew, P. (Contributor), Chen, L. (Contributor), Huang, R. (Creator), Lai, H. (Contributor) & Chang, L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
Dataset